Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Haobo Ren"'
Autor:
Eric L. Simpson, Robert Bissonnette, Zelma C. Chiesa Fuxench, Howard Kallender, Daniel Sturm, Haobo Ren, Linda F. Stein Gold
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
AbstractPurpose: Ruxolitinib (selective Janus kinase [JAK] 1 and JAK2 inhibitor) cream demonstrated efficacy and safety in patients with atopic dermatitis (AD) in the phase 3 TRuE-AD studies. In TRuE-AD1/TRuE-AD2 (NCT03745638/NCT03745651), adults and
Externí odkaz:
https://doaj.org/article/c36f0aecbfc449cc9a00f76ee57f6056
Publikováno v:
Journal of Materials Research and Technology, Vol 20, Iss , Pp 3456-3470 (2022)
The anisotropy in creep aging behavior and microstructural evolution of AA2195-T34 A l–Li alloy plates under different stress levels at 180 °C were systematically investigated by constant-stress creep aging, mechanical property testing and microst
Externí odkaz:
https://doaj.org/article/2db008f516e34435b49c1b4127e8bf24
Autor:
Di Tie, Haobo Ren, Renguo Guan, Weirong Li, Hongchao Li, Yuxiang Wang, Junjia Zhang, Lei Li, Deliang Zhang, Minfang Chen
Publikováno v:
Materials Research Express, Vol 7, Iss 5, p 056525 (2020)
To reveal the formation and wear mechanisms of rheo-formed aluminum alloy - B _4 C composites, A356 alloy − 10 mass% B _4 C composite material was fabricated by semi-solid stirring rheo-casting and rolling process. The presence of Al _3 BC was conf
Externí odkaz:
https://doaj.org/article/9490f91aba914fcb9a58a612b9e38bf8
Autor:
Ghassan K. Abou-Alfa, Kristen Bibeau, Nikolaus Schultz, Amin Yaqubie, Brittanie Millang, Haobo Ren, Luis Féliz
Publikováno v:
Targeted Oncology. 17:517-527
First-line standard-of-care therapy for advanced cholangiocarcinoma is gemcitabine plus cisplatin; there is no established second-line systemic therapy. Fibroblast growth factor receptor (FGFR)-2 fusions/rearrangements can be oncogenic drivers, occur
Autor:
Biqin Dong, Hanquan Diao, Haobo Ren, Shuxian Hong, Yanshuai Wang, Guohao Fang, Yuanyuan Zhang
Publikováno v:
Cement and Concrete Composites. 141:105144
Publikováno v:
JCO Precision Oncology.
PURPOSE Oncogenic fibroblast growth factor receptor (FGFR) gene alterations have been described in patients with cholangiocarcinoma (CCA). This post hoc analysis assessed progression-free survival (PFS) in patients who had received first- or second-l
Autor:
Kim Papp, Jacek C. Szepietowski, Leon Kircik, Darryl Toth, Lawrence F. Eichenfield, Seth B. Forman, Michael E. Kuligowski, Howard Kallender, Kang Sun, Haobo Ren, Eric L. Simpson
Publikováno v:
Journal of the American Academy of Dermatology.
Ruxolitinib cream demonstrated safety and efficacy over 8 weeks in two double-blind phase 3 atopic dermatitis studies (NCT03745638/NCT03745651).Evaluate long-term safety (LTS) and disease control with ruxolitinib cream.Patients initially randomized t
Publikováno v:
European Journal of Environmental and Civil Engineering. 26:3258-3275
Ancient Chinese heritage buildings have high historical and artistic value. The bracket set in heritage buildings plays an important role in transferring and bearing load. However, over time, damag...
Autor:
Srdan Verstovsek, Patricia Kalafut, Robyn M. Scherber, Rami S. Komrokji, Haobo Ren, Brady L. Stein
Publikováno v:
Blood. 136:49-51
Background: Myelofibrosis (MF) is a chronic Philadelphia chromosome-negative myeloproliferative neoplasm (MPN) characterized by extramedullary hematopoiesis, bone marrow fibrosis, splenomegaly, constitutional symptoms, and diminished quality of life.
Autor:
Roger M, Lyons, David, Lessen, Salman, Fazal, Robyn, Scherber, Patricia, Kalafut, Haobo, Ren, Ellen, Ritchie
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S329
Myelofibrosis and Essential Thrombocythemia Observational STudy (MOST) (NCT02953704) is an ongoing observational study in essential thrombocythemia (ET) or myelofibrosis (MF) patients enrolled in academic (AC) and community (CC) centers throughout th